NYR
NYRADA INC. CDI 1:1 USPROHIBITEDNyrada Inc., a clinical-stage biotechnology company, focuses on the discovery and development of small-molecule therapies for neuroprotection and cardioprotection indications in Australasia. Its lead candidate is Xolatryp, a small-molecule inhibitor targeting the transient receptor potential canonical ion channel subtypes 3, 6, and 7, which is in a Phase IIa clinical trial to treat myocardial ischemia, arrhythmia, stroke, and traumatic brain injury, as well as in a preclinical research stage for oncology indications. Nyrada Inc. was incorporated in 2017 and is based in Sydney, Australia.
NYR
NYR
NYRADA INC. CDI 1:1 USPROHIBITED
Nyrada Inc. , a clinical-stage biotechnology company, focuses on the discovery and development of small-molecule therapies for neuroprotection and cardioprotection indications in Australasia.
Fundamentals
Historical Data29 days
| Date | Short % | Gross Short |
|---|---|---|
| 25 Sept | — | — |
| 24 Sept | — | — |
| 23 Sept | — | — |
| 22 Sept | 0.00% | — |
| 21 Sept | — | — |
| 18 Sept | — | — |
| 17 Sept | — | — |
| 16 Sept | — | — |
| 15 Sept | — | — |
| 14 Sept | — | — |
| 11 Sept | — | — |
| 10 Sept | — | — |
Nyrada Inc. CDI 1:1 Usprohibited (NYR) Short Interest Summary
Nyrada Inc. CDI 1:1 Usprohibited (NYR) currently has 0.00% of its shares sold short (0 thousand shares, worth approximately $0K), based on ASIC short position data reported on 22 September 2026 (T+4 reporting lag). That makes NYR the #742 most shorted stock on the ASX most shorted list. NYR is part of the Health Care sector on the ASX.
Recent NYR Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 22 Sept 2026 | 0.00% | 0.0M | $0.60 |
| 4 Sept 2026 | 0.00% | 0.0M | $0.73 |
NYR Short Selling — Frequently Asked Questions
What is Nyrada Inc. CDI 1:1 Usprohibited (NYR)'s current short interest?
Nyrada Inc. CDI 1:1 Usprohibited (NYR) currently has a short interest of 0.00% of total shares outstanding. This means 0.00% of NYR's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is NYR heavily shorted on the ASX?
NYR has a relatively low short interest of 0.00%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for NYR investors?
Short interest in NYR shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 0.00%, NYR's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this NYR short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for NYR.